Rwanda’s Ministry of Health has signed a three-year partnership with the GX Foundation aimed at strengthening the country’s efforts to prevent and control malaria and other vector-borne diseases.
The agreement will support malaria prevention, early detection and community-level interventions through the distribution of thousands of diagnostic kits, mosquito nets and vector-control equipment.
Under the partnership, 36,000 rapid diagnostic test kits will be provided to support the detection of malaria cases and enable people suspected of infection to access appropriate treatment more quickly.
The initiative will also deliver 18,000 mosquito nets, providing an additional layer of protection against mosquito bites, which remain a major pathway for malaria transmission.
Beyond conventional prevention measures, the programme includes 6,500 mosquito-killing lamps designed to help reduce mosquito populations, as well as more than 320,000 fly traps targeting other disease-carrying vectors.
The scale of the intervention means the programme will deploy over 380,000 vector-control and diagnostic items, excluding community awareness materials. This includes more than 320,000 fly traps alone, making vector control a major component of the partnership.
The collaboration will also incorporate community awareness materials, with the aim of strengthening public knowledge about malaria prevention, early testing and other measures for reducing exposure to disease-carrying insects.
The three-year timeframe is expected to allow the interventions to be implemented through sustained community-based efforts rather than as a one-off campaign.
Malaria remains a public-health concern in Rwanda, where prevention, early diagnosis and effective treatment are key components of efforts to reduce the burden of the disease.
Through the agreement, the Ministry of Health and the GX Foundation are seeking to combine medical detection with household and community-level vector control, reinforcing Rwanda’s broader strategy of preventing malaria and other vector-borne diseases.
The partnership comes as Rwanda continues to invest in measures that reduce exposure to disease vectors while improving the ability of communities and health services to identify and respond to infections.
